Search

PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...

The use of artificial intelligence (AI) in health care, and specifically, as the utilization of software in medical devices continues to increase. Machine learning (ML) is a branch of AI in which computer systems automatically adapt, improve, and make predictions by applying algorithms to analyze...

Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...

Gianna Arnold helps companies protect, leverage and enforce their intellectual property and develop and memorialize strategic alliances in service to their goal of enhancing their value. Her understanding of the importance of these assets to the bottom line of a business stems in part from her past...

Companies planning to develop and commercialize medical devices or diagnostics face a challenging financing, regulatory, reimbursement and liability environment. Saul Ewing attorneys are experienced in helping medical device and diagnostic companies navigate these challenges. Many members of our...

Jessica Lenoir, Ph.D., helps clients protect their intellectual property by drafting patent applications and preparing office action responses to the U.S. Patent and Trademark Office and foreign offices. In handling this work, Jessica draws on her knowledge from earning a doctorate in...

Jeff Shapiro handles sophisticated litigation nationwide for companies facing allegations of defective products and other crises that threaten their business, often in the context of multi-district litigation and class actions. During his 40 years as a trial lawyer, manufacturers of medical devices...

Sherry Flax concentrates her practice on matters dealing with intellectual property law, with an emphasis on trademarks and copyrights. She assists clients in securing and protecting their rights in commercially valuable property through U.S. and international trademarks and copyrights, domain names...

Alyson Leone guides clients in the health care industry through corporate transactions that shape the growth and development of their business. Drawing on 20 years of legal experience, Alyson advises on the formation and structuring of entities including physician and dental practices, ambulatory...

New discoveries and a platform to develop them into products are the lifeblood of the biotechnology industry. As technology advances, opportunities for collaboration continue to drive development of DNA-based and other biological and cell-based products. But the journey to the marketplace is fraught...

Navigating the Legal Complexities of an Evolving Industry Launching a cannabis business, whether related to medical- or adult-use in states where it has been authorized, requires tenacity. It also demands an appreciation for the complexities of the evolving and conflicting federal, state and local...

Adam B. Cantor draws on 25 years of legal practice to advise clients on a wide array of executive and equity compensation, deferred compensation, and employee benefits matters. Clients look to Adam to provide practical, business-oriented legal advice that frequently integrates multiple areas of law...

Drawing on his experience as a former general counsel for two companies, Zack Kobrin is a transactional and regulatory lawyer who understands that business clients want practical advice on how to complete deals and navigate complex statutory and regulatory regimes affecting their growth and daily...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...

Peri Berger represents clients facing complex commercial disputes involving breach of contract, fraud, business ownership and control, intellectual property, trade secrets and other threats related to their operations in state and federal courts in New York, New Jersey and across the country. Peri...

Tom Murray is a patent agent who helps clients protect their intellectual property through patent preparation and prosecution, as well as analyses involving freedom to operate, non-infringement and invalidity. Tom also has experience with matters involving post-grant prosecutions. His IP work for...

Andrew Schwerin represents clients in patent and trade secret litigation on both the plaintiff and defense sides of these disputes. Outside of his litigation work, Andrew counsels clients on their IP strategy. Andrew has represented clients in connection with a range of technologies including...

Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...